Trial Profile
A retrospective study to evaluate the romiplostim in the management of the thrombocytopenic surgical patient.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Romiplostim (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 09 Feb 2016 New trial record